Syringes Market - Forecast(2022 - 2027)

Report Code: HCR 0518 Report Format: PDF + Excel

Syringes Market Overview

Syringes Market Size is estimated to reach $17.1 billion by 2027. Furthermore, it is poised to grow at a CAGR of 9.8% over the forecast period of 2022-2027. A syringe is a simple reciprocating pump with a plunger that fits securely within a barrel, which is a cylindrical tube. The syringe may take in and expel liquid or gas through a discharge aperture at the front end of the tube by linearly pulling and pushing the plunger along the inside of the tube. Generally, these are used to inject or withdraw fluids from the body using a needle, especially a hypodermic needle. Nowadays, plastic syringes are widely used as they are disposable after initial use which ensures safe use of the same.

Mostly, in chronic and Infectious diseases syringes are used since intravenous therapy in fatal and resistant Infectious diseases and subcutaneous Insulin in type-1 diabetes are required treatments. Generally, syringes need a lubricant but the BD Luer-Lok syringe is lubricant-free to prevent side effects owing to lubricant. Currently, Intravenous and subcutaneous Insulins are available in the market for type-1 diabetes patients. The COVID-19 pandemic led to enhance the use of syringes for vaccines and other diseases such as thromboembolism owing to clots induced by COVID-19. In addition, Intravenous antimicrobials are preferred in severe infections induced by COVID -19. Thus, COVID 19 and Chronic diseases are driving the Syringes Industry.

Syringes Market Report Coverage

The report: “Syringes Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Syringes Market.

By Product type – General syringes, Specialised syringes, and Smart syringes.
By Usage – Disposable syringes and Reusable syringes.
By Material – Glass, Plastic syringes.
By Distribution channel – Online and offline.
By End Users – Hospitals, Ambulatory Centres, Clinics, Community Healthcare, and Others.
By Geography – North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and the Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key takeaways

  • Geographically, North America held a dominant market share in the year 2021 on account of the increasing prevalence of chronic diseases. Asia-Pacific is estimated to offer lucrative growth opportunities to the manufacturers owing to the increasing prevalence of Chronic diseases., demand for better healthcare facilities as well a boost in the investments done by government and private companies in the pharma industry.  The proliferation of Chronic diseases especially type-1 diabetes is predicted to augment the market growth during the forecast period of 2022-2027.
  • Chronic diseases are estimated to drive the market growth of the Syringes Market.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Syringes Market Report.

Syringes Market: Market Share (%) by region, 2021

Syringes Market

For more details on this report - Request for Sample

Syringes Market Segmentation Analysis - By Usage

Syringes Market based on drug type can be further segmented into disposable and reusable. Disposables held a dominant market share in the year 2021 primarily owing to safety and are estimated to be the fastest-growing, with a CAGR of 10.4% over the forecast period of 2022-2027. Disposable syringes are sterile and used only one time which ensures the safety and moreover prevents fatal infections. According to World Health Organisation (WHO), in the year 2016, Infectious diseases can be prevented by using disposable syringes are the major reason for the increasing market for disposable syringes. Nevertheless, prefilled syringes are going to be popularised in the future as per WHO.

According to Occupational Safety and Health Administration (OSHA) estimates, in the year 2000, every year around 384,000 health care professionals suffer from needle stick injuries, thereby, enhancing the segment expansion.

Syringes Market Segmentation Analysis - By Material

Syringes Market based on drug type can be further segmented into Plastic and glass. Plastic held a dominant market share in the year 2021 primarily owing to reusable and is estimated to be the fastest-growing, with a CAGR of 10.6% over the forecast period of 2022-2027. Plastic Injection-molded syringes made from polypropylene resin. The plunger, main body, which is graduated to show capacity, gasket, needle holder, and needle sheath cover are among the components.  According to NCBI, in 2000, plastic syringes are used as a single shot during vaccination. Plastic syringes are reusable and can be discarded after one shot. However, glass syringes are sterile but they are fragile and expensive to manufacture, thus generating Plastic syringes revenue.

Syringes Market Segmentation Analysis – By Geography

The Syringes market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 32% in the year 2021 as compared to the other counterparts on account of well-developed healthcare infrastructure, increasing prevalence of infectious diseases, and higher purchasing power of the consumers. For instance, the Development Finance Corporation had approved a $590 million loan to support construction that can produce up to 3 billion single-dose prefilled plastic injectors.

However, Asia Pacific is estimated to be the fastest-growing, over the forecast period of 2022-2027 owing to the pandemic and increasing use of syringes in hospitals owing to the high number of hospitalizations and vaccinations. These hospitalizations are followed by a series of tests involving blood samples and the injection of various medications to manage the virus's symptoms which are projected to enhance even more.

Furthermore, Syringes Market is estimated to be growing in the Asia Pacific region as participants are always focused on product introductions, which is propelling the region's market expansion. For example, Sunshine Guojian Pharmaceutical, a subsidiary of 3SBio, reported in August 2019 that Yisaipu, a biosimilar of Enbrel (etanercept), had been approved in China as a pre-filled syringe to treat ankylosing spondylitis.

Syringes Market Drivers

Prevalence of chronic diseases like Type-1 Diabetes, Hypertension is driving the Market for Syringes

The enhancement in the prevalence of chronic diseases like type-1 diabetes which is also called Insulin Dependent Diabetes Mellitus (IDDM). According to International Diabetes Federation,  In 2021, approximately 537 million adults (20-79 years) are living with diabetes and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. 3 in 4 adults with diabetes live in low- and middle-income countries and almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Further, Diabetes caused 6.7 million deaths in 2021. Currently, Insulin is the option available for IDDM treatment. As Insulin is a hormone as its large size and sensitivity to gastrointestinal enzymes cannot be absorbed orally. Thus, it needs to be administered subcutaneously and rarely intravenously by using a specialized syringe named Insulin syringe. Additionally, in emergency and resistant cases; Insulin is the only option available even for type-2 diabetes patients. Hence, Chronic diseases are the key factor driving the growth of the syringes market.

Usage of syringes in COVID-19 and other infectious disease like Hepatitis B vaccination is driving the Syringes Market

Vaccines are biological preparations that can prevent infectious diseases by developing immunity against fatal and untreatable infections, especially in children. According to United Nations International Children's Emergency Fund (UNICEF), Measles vaccines alone are estimated to have prevented around 21 million deaths between 2000-2017. The maximum number of vaccines are administered through syringes. Vaccines are majorly administered to children to immunize to prevent fatal and untreatable infections. UNICEF is the largest member to purchase auto disposable syringes; 40% of the global market. Thus, vaccines are one of the supreme factors driving the market for syringes.

Syringes Market Challenges

Needlestick injuries of syringes poses threat to market growth.

Needlestick injuries are a major challenge for syringes; can cause infections primarily including HIV, HBV, and HCV. According to the Centers for Disease Control and Prevention (CDC) in 2018, an estimated 600,000 to 800,000 needle stick injuries occurred. Nurses and other healthcare professionals face a severe risk of needlestick injuries. One of the most serious clinical consequences of needlestick injuries is the danger of contracting blood-borne illnesses like hepatitis and HIV. To reduce the danger and impact of needlestick injuries, a variety of interventions have been implemented, including the use of fixed-needle safety syringes. Some healthcare providers, on the other hand, reject the utilization of such devices for a variety of reasons, including the apparent requirement to replace syringe needles between preparing medicine and administering it to a patient. Hence, Needlestick injuries are one of the challenges for Syringes Market.

Syringes Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Syringes Market. The top syringes Market companies are-

  1. Becton Dickinson
  2. Braun Melsungen
  3. Terumo
  4. Teleflex
  5. Nipro
  6. Smith’s Medical
  7. Cardinal Health
  8. Phenomenex, Inc
  9. Hutchins & Hutchins
  10. Qosina corp.

Recent Developments

  • In October 2019, Becton Dickinson, launched BD Intevi 1mL two-step disposable autoinjector, a device that combines an autoinjector and a pre-fillable syringe in one integrated system, which has been released by BD. The BD autoinjector is a new generation of BD autoinjectors that will allow medication producers to improve drug administration in a seamless manner. The platform technology is meant to make self-injecting easier for patients.
  • In September 2019, Braun Melsungen in collaboration with Royal Philips launched vision needle tip tracking to ensure accurate positioning of the needle in the body. It helps anesthesiologists to perform anesthesia procedures in a safe and effective manner by avoiding complications such as peripheral nerve blocks.
  • In December 2020, Smiths Medical launched the Echoglo needle for peripheral nerve block has been launched. With a combination of clockwise and counter-clockwise grooves, the grooves are designed to reflect acoustic energy back to the transducer, making echogenic visibility possible.

Relevant Reports:

Report Code: HCR 0671

Report Code: HCR 0064

Report Code: HCR 0177

For more Lifesciences and Healthcare related reports, please click here

1. Syringes Market - Overview
    1.1 Definitions and Scope
2. Syringes Market - Executive Summary
3. Syringes Market - Comparative Analysis
    3.1 Company Benchmarking - Key Companies
    3.2 Global Financial Analysis Key Companies
    3.3 Market Share Analysis Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Syringes Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Syringes Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing Business Index
    5.3 Case Studies of Successful Ventures
6. Syringes Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Syringes Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Syringes Market – By Product type
    8.1 General syringes
    8.2 Specialized syringes
        8.2.1 Insulin syringes
        8.2.2 Tuberculin syringes
        8.2.3 Allergy syringes
        8.2.4 Other syringes
    8.3 Smart syringes
9. Syringes Market – By Usage
    9.1 Disposable syringes
    9.2 Reusable syringes
10. Syringes Market – By Material
    10.1 Glass syringes
    10.2 Plastic syringes
11. Syringes Market – By Distribution channel
    11.1 Online
    11.2 Offline
12. Syringes Market – By End Users
    12.1 Hospitals
    12.2 Ambulatory Centers
    12.3 Clinics
    12.4 Community Health care
    12.5 Others
13. Syringes Market - By Geography
    13.1 North America
        13.1.1 U.S.
        13.1.2 Canada
        13.1.3 Mexico
    13.2 Europe
        13.2.1 U.K.
        13.2.2 Germany
        13.2.3 France
        13.2.4 Italy
        13.2.5 Spain
        13.2.6 Russia
        13.2.7 Rest of Europe
    13.3 Asia-Pacific
        13.3.1 China
        13.3.2 India
        13.3.3 Japan
        13.3.4 South Korea
        13.3.5 Australia & New Zealand
        13.3.6 Rest of Asia-Pacific
    13.4 South America
        13.4.1 Brazil
        13.4.2 Argentina
        13.4.3 Chile
        13.4.4 Colombia
        13.4.3 Rest of South America
    13.5 Rest of the World
        13.5.1 Middle East
        13.5.2 Africa
14. Syringes Market - Entropy
15. Syringes Market – Industry/Segment Competition Landscape Premium 
    15.1 Market Share Analysis
        15.1.1 Global Market Share – Key Companies
        15.1.2 Market Share by Region – Key companies
        15.1.3 Market Share by Countries – Key Companies
    15.2 Competition Matrix
    15.3 Best Practices for Companies
16. Syringes Market – Key Company List by Country Premium Premium
17. Syringes Market - Company Analysis
    17.1 Company 1
    17.2 Company 2
    17.3 Company 3
    17.4 Company 4
    17.5 Company 5
    17.6 Company 6
    17.7 Company 7
    17.8 Company 8
    17.9 Company 9
    17.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.